FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations
This article was originally published in The Pink Sheet Daily
Executive Summary
Rapid approval of a new, preservative-free generic methotrexate and permission to import an unapproved version of doxorubicin touted at press conference as FDA emphasizes the success of administrative efforts.
You may also be interested in...
FDA Envisions Flexible Approach To Expanded Use Of Accelerated Approval
In its desktop reference guidance on the four expedited regulatory pathways, FDA broadens its view of when an investigational drug fills an “unmet medical need” and guides sponsors through the use of intermediate clinical endpoints as a basis for accelerated approval.
Drug Shortages Give Ben Venue Relief In FDA Consent Decree
The consent decree permits the company to continue to manufacture more than 100 drugs, 20 of which are on FDA’s current drug shortage list. Ben Venue must prove compliance with good manufacturing practice requirements before it can manufacture its other drugs.
Drug Shortages Give Ben Venue Relief In FDA Consent Decree
The consent decree permits the company to continue to manufacture more than 100 drugs, 20 of which are on FDA’s current drug shortage list. Ben Venue must prove compliance with good manufacturing practice requirements before it can manufacture its other drugs.